Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Moderna Inc (MRNA)
Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,137,840
  • Shares Outstanding, K 381,209
  • Annual Sales, $ 19,263 M
  • Annual Income, $ 8,362 M
  • 60-Month Beta 1.70
  • Price/Sales 2.58
  • Price/Cash Flow 5.65
  • Price/Book 2.60
Trade MRNA with:

Options Overview Details

View History
  • Implied Volatility 43.05% ( -0.57%)
  • Historical Volatility 40.74%
  • IV Percentile 2%
  • IV Rank 2.69%
  • IV High 81.35% on 06/13/22
  • IV Low 41.99% on 05/22/23
  • Put/Call Vol Ratio 1.19
  • Today's Volume 27,387
  • Volume Avg (30-Day) 40,369
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 355,811
  • Open Int (30-Day) 343,473

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -3.80
  • Number of Estimates 11
  • High Estimate -2.01
  • Low Estimate -4.65
  • Prior Year 5.24
  • Growth Rate Est. (year over year) -172.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.56 +3.54%
on 05/17/23
142.79 -11.13%
on 05/24/23
-10.14 (-7.40%)
since 05/05/23
3-Month
122.56 +3.54%
on 05/17/23
163.24 -22.26%
on 04/14/23
-17.13 (-11.89%)
since 03/06/23
52-Week
115.03 +10.32%
on 09/29/22
217.25 -41.59%
on 12/14/22
-13.10 (-9.36%)
since 06/06/22

Most Recent Stories

More News
Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of distant metastasis or death by 65% (HR=0.347 [95% CI, 0.145-0.828]); one-sided p value=0.0063) compared to KEYTRUDA alone

MRNA : 126.90 (-1.55%)
MRK : 110.01 (-2.74%)
Growth Stocks Look Primed for a Rally. Is It Time to Jump Back In?

For most investors, it was never time to abandon growth stocks.

WMT : 149.78 (-0.01%)
KO : 60.31 (-0.72%)
AMZN : 126.61 (+1.05%)
PTON : 8.26 (+0.98%)
ZM : 69.50 (+0.70%)
MRNA : 126.90 (-1.55%)
Better Healthcare AI Stock: Moderna vs. Doximity

The healthcare AI market is forecast to top $100 billion a few years from now.

MRNA : 126.90 (-1.55%)
DOCS : 34.06 (+0.29%)
IBM : 132.69 (+0.04%)
Moderna to Present at Upcoming Conferences in June 2023

CAMBRIDGE, MA / ACCESSWIRE / June 1, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following...

MRNA : 126.90 (-1.55%)
COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?

Does this latest surge significantly improve the investment thesis for Moderna?

MRNA : 126.90 (-1.55%)
2 Healthcare AI Stocks to Buy on the Dip

These stocks are trading at bargain prices right now.

MRNA : 126.90 (-1.55%)
MDT : 83.60 (-0.16%)
Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Admin

MRNA : 126.90 (-1.55%)
PFE : 38.37 (-0.72%)
IOVA : 8.18 (-0.49%)
NVS : 99.66 (+0.29%)
BMY : 65.48 (-0.76%)
MRK : 110.01 (-2.74%)
If You Invested $2,500 in Moderna in 2019, This Is How Much You Would Have Today

You'd have a lot more money, but only if you resisted the temptation to take the initial profits.

MRNA : 126.90 (-1.55%)
Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting

ASCO presentations on Saturday, June 3 at 4:30pm CDT and Monday, June 5 at 3:00pm CDT

MRNA : 126.90 (-1.55%)
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?

These companies haven't given up on the coronavirus vaccine market.

MRNA : 126.90 (-1.55%)
PFE : 38.37 (-0.72%)
NVAX : 7.23 (-7.90%)
OCGN : 0.4700 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 133.52
2nd Resistance Point 131.33
1st Resistance Point 129.12
Last Price 126.90
1st Support Level 124.72
2nd Support Level 122.53
3rd Support Level 120.32

See More

52-Week High 217.25
Fibonacci 61.8% 178.20
Fibonacci 50% 166.14
Fibonacci 38.2% 154.08
Last Price 126.90
52-Week Low 115.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar